Land: Irland
Sprache: Englisch
Quelle: HPRA (Health Products Regulatory Authority)
CLOXACILLIN BENZATHINE
Zoetis Ireland Limited
QJ51CF02
CLOXACILLIN BENZATHINE
600 mg/syringe
intramammary Suspension
POM
Bovine
Cloxacillin
Antibacterial
Authorised
2014-05-02
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Orbenin Extra Dry Cow 600 mg Intramammary Suspension 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 3.6g syringe contains Active Substance Cloxacillin (as Cloxacillin Benzathine) 600mg Excipients Mineral oil base to 3.6g For a full list of excipients see section 6.1. 3 PHARMACEUTICAL FORM Intramammary suspension. A white to off-white viscous suspension. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cows 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For use in cows at drying off, to treat existing mastitis infections and to provide protection against further infections during the dry period. 4.3 CONTRAINDICATIONS Do not use in the lactating cow. If a lactating cow is accidentally infused, milk should be withheld from the bulk supply for 46 days or less time if testing shows the level of cloxacillin in the milk to be within the WHO tolerance limit of 0.02 µg/ml (ppm). In common with all other penicillins, cloxacillin should not be used orally or parenterally in rabbits, guinea-pigs, hamsters or gerbils. Caution is advised in its use in other very small herbivores. Do not use in animals with known hypersensitivity to the active ingredient. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 21/07/2016_ _CRN 7024143_ _page number: 1_ 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTION(S) FOR USE None. SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS Penicillins and cephalosporins may cause hypersensitivity (allergy) following injection, inhalation, ingestion or skin contact. Hypersensitivity to penicillins ma Lesen Sie das vollständige Dokument